KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Nektar Therapeutics (NKTR) over the last 13 years, with Q2 2025 value amounting to $552307.0.

  • Nektar Therapeutics' Treasury Shares changed 0.0% to $552307.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $552307.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $552307.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q2 2025, Nektar Therapeutics' Treasury Shares is $3.0 million, which was down 0.0% from $3.0 million recorded in Q1 2025.
  • In the past 5 years, Nektar Therapeutics' Treasury Shares ranged from a high of $9.9 million in Q4 2021 and a low of -$552307.0 during Q1 2024
  • Moreover, its 4-year median value for Treasury Shares was $552307.0 (2024), whereas its average is $2.7 million.
  • Within the past 5 years, the most significant YoY rise in Nektar Therapeutics' Treasury Shares was 0.0% (2025), while the steepest drop was 0.0% (2025).
  • Quarter analysis of 2 years shows Nektar Therapeutics' Treasury Shares stood at $3.0 million in 2024, then changed by 0.0% to $3.0 million in 2025.
  • Its Treasury Shares was $552307.0 in Q2 2025, compared to $552307.0 in Q1 2025 and $552307.0 in Q4 2024.